These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines. Conti P; D'Ovidio C; Conti C; Gallenga CE; Lauritano D; Caraffa A; Kritas SK; Ronconi G Eur J Pharmacol; 2019 Feb; 844():87-94. PubMed ID: 30529470 [TBL] [Abstract][Full Text] [Related]
7. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027 [TBL] [Abstract][Full Text] [Related]
8. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition. Conti P; Lessiani G; Kritas SK; Ronconi G; Caraffa A; Theoharides TC Tissue Cell; 2017 Jun; 49(3):393-400. PubMed ID: 28420489 [TBL] [Abstract][Full Text] [Related]
9. Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37. Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Martinotti S Eur J Pharmacol; 2020 May; 875():173035. PubMed ID: 32097657 [TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells. Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328 [TBL] [Abstract][Full Text] [Related]
11. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Woolley DE; Tetlow LC Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391 [TBL] [Abstract][Full Text] [Related]
12. Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation. Conti P; Ronconi G; Lauritano D; Mastrangelo F; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Carinci F; Gaudelli F; Annicchiarico C; D'Ovidio C Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542222 [TBL] [Abstract][Full Text] [Related]
13. Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members. Robuffo I; Toniato E; Tettamanti L; Mastrangelo F; Ronconi G; Frydas I; Caraffa Al; Kritas SK; Conti P J Biol Regul Homeost Agents; 2017; 31(4):837-842. PubMed ID: 29254286 [TBL] [Abstract][Full Text] [Related]
14. Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37. Trimarchi M; Lauritano D; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Calvisi V; Conti P Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362030 [TBL] [Abstract][Full Text] [Related]
15. Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial. Conti P; Ronconi G; Kritas SK; Caraffa A; Theoharides TC Can J Diabetes; 2018 Oct; 42(5):568-573. PubMed ID: 29885882 [TBL] [Abstract][Full Text] [Related]
16. CAR-T cell therapy causes inflammation by IL-1 which activates inflammatory cytokine mast cells: anti-inflammatory role of IL-37. Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Di Emidio P; Conti P J Biol Regul Homeost Agents; 2019; 33(6):1981-1985. PubMed ID: 31920059 [TBL] [Abstract][Full Text] [Related]
17. Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues. Conti P; Caraffa Al; Kritas SK; Ronconi G; Lessiani G; Toniato E; Theoharides TC J Biol Regul Homeost Agents; 2017; 31(2):263-267. PubMed ID: 28685525 [TBL] [Abstract][Full Text] [Related]
18. Impact of mold on mast cell-cytokine immune response. Kritas SK; Gallenga CE; D Ovidio C; Ronconi G; Caraffa Al; Toniato E; Lauritano D; Conti P J Biol Regul Homeost Agents; 2018; 32(4):763-768. PubMed ID: 30043558 [TBL] [Abstract][Full Text] [Related]
19. Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2. Franke K; Wang Z; Zuberbier T; Babina M Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808264 [TBL] [Abstract][Full Text] [Related]
20. Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren's Syndrome: Promising Inhibitory Effect of IL-37. Conti P; Stellin L; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]